We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$226M
AUM Growth
+$8.04M
Cap. Flow
+$19.3M
Cap. Flow %
8.51%
Top 10 Hldgs %
97.2%
Holding
30
New
8
Increased
4
Reduced
2
Closed
8

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 68.73%
2 Healthcare 6.75%
3 Financials 6.19%
4 Technology 1.11%
5 Industrials 0.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
W icon
1
Wayfair
W
$12.5B
$155M 68.35%
4,413,282
ENVI
2
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$14.9M 6.58%
3,639,939
HAPN
3
Happen Inc
HAPN
$2.19B
$14M 6.19%
211,867
-31,000
-13% -$2.11M
ZAYO
4
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$12.8M 5.66%
+505,109
New +$13.6M
FNJN
5
DELISTED
Finjan Holdings, Inc.
FNJN
$7.1M 3.14%
4,303,435
SAGE
6
DELISTED
Sage Therapeutics
SAGE
$6.93M 3.06%
163,819
+102,639
+168% +$6.33M
LRMR icon
7
Larimar Therapeutics
LRMR
$398M
$3.58M 1.58%
9,325
+2,872
+45% +$1.29M
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
$3.27M 1.45%
35,618
+14,518
+69% +$1.26M
QLYS icon
9
Qualys
QLYS
$4.78B
$1.37M 0.61%
+48,184
New +$1.62M
AWAY
10
DELISTED
HOMEAWAY INC COM
AWAY
$1.33M 0.59%
50,244
SCTY
11
DELISTED
SolarCity Corporation
SCTY
$1.23M 0.54%
28,870
-10,000
-26% -$502K
FMI
12
DELISTED
Foundation Medicine, Inc.
FMI
$1.04M 0.46%
56,567
VTAE
13
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$938K 0.41%
+85,217
New +$905K
PBPB
14
DELISTED
Potbelly
PBPB
$844K 0.37%
76,671
+60,869
+385% +$730K
BOX icon
15
Box
BOX
$4.36B
$797K 0.35%
+63,369
New +$944K
MESG
16
DELISTED
XURA INC COM (DE)
MESG
$397K 0.18%
+17,734
New +$355K
ATRA icon
17
Atara Biotherapeutics
ATRA
$70.4M
$331K 0.15%
+422
New +$515K
ECOM
18
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$283K 0.13%
28,512
MOBL
19
DELISTED
MobileIron, Inc.
MOBL
$273K 0.12%
+88,066
New +$405K
OPWR
20
DELISTED
OPOWER INC COM STK (DE)
OPWR
$71K 0.03%
7,939
EPZM
21
DELISTED
Epizyme, Inc
EPZM
$67K 0.03%
5,196
TSRO
22
DELISTED
TESARO, Inc.
TSRO
$62K 0.03%
+1,539
New +$84.1K
ARDX icon
23
Ardelyx
ARDX
$1.25B
-32,584
Closed -$520K
META icon
24
Meta Platforms (Facebook)
META
$1.51T
-5,993
Closed -$514K
INXN
25
DELISTED
Interxion Holding N.V.
INXN
-72,058
Closed -$1.99M

Similar funds

Harbourvest Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Harbourvest Partners held 30 positions worth $226M, up 3.7% from $218M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Harbourvest Partners deployed $19.3M of net new capital in Q3 2015, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 505,109 shares worth $12.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 69% of assets, down from 76% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Happen Inc, an estimated $2.11M trimmed.

  • Harbourvest Partners's largest Q3 2015 buy was Zayo Group Holdings, Inc.: 505,109 shares worth $12.8M.
  • Harbourvest Partners added most to Sage Therapeutics in Q3 2015, an estimated $6.33M increase.
  • Harbourvest Partners's biggest Q3 2015 reduction was Happen Inc, cutting an estimated $2.11M.
  • Harbourvest Partners fully exited Interxion Holding N.V. in Q3 2015, selling an estimated $1.99M.
  • Harbourvest Partners's ten largest holdings make up 97% of its $226M portfolio in Q3 2015.
  • Harbourvest Partners opened 8 new positions and closed 8 in Q3 2015.
  • Harbourvest Partners's portfolio value rose 3.7% quarter-over-quarter to $226M.

Based on Harbourvest Partners's 13F filing for Q3 2015, filed 13 Nov 2015.